Preemer Trial - Prophylactic Mesh Versus no Mesh in the Midline Emergency Laparotomy Closure for Prevention of Incisional Hernia: a Multi Center, Double-blind, Randomized Controlled Trial

NCT ID: NCT04311788

Last Updated: 2024-02-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

109 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-04-27

Study Completion Date

2028-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

244 patients, who have an emergency midline laparotomy for any gastrointestinal reason, will be randomized in a 1:1 ratio either to mesh group with a retrorectus prophylactic self-gripping mesh or to control group with 4:1 small stitch closure by continuous monofilament suture. They will be followed up at 30 days, 2 and 5 years to detect the incidence of incisional hernia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Incisional hernia (IH) is a common complication of abdominal wall surgery. Its' incidence varies greatly (2-30 %) among studies. The incisional hernia incidence is influenced by several factors, such as closing technique, follow-up time and the modality of radiological investigations, patient characteristics and co-morbidities as well as indication and type for surgery.

European Hernia Society (EHS) guideline strongly recommends to utilise a non-midline approach to a laparotomy whenever possible to decrease the incidence of incisional hernia. However, this is clearly not an option in an emergency laparotomy, as midline incision is the fastest and the best visualizing opening to explore the whole abdominal cavity in an emergency setting.

For elective midline incisions, evidence-based recommendation is to perform a continuous suturing technique with slowly absorbable monofilament suture when closing the incision. Suturation should be done performing a single layer aponeurotic closure technique without separate closure of the peritoneum. A small bites technique with a suture to wound length (SL/WL) ratio at least 4:1 is the current recommended method of fascial closure.

Prophylactic mesh augmentation in a non-emergency setting appears effective and safe and can be suggested for high-risk patients. However, no recommendations can be given on the optimal technique to close emergency laparotomy incisions because of lack of evidence. This problem should be emphasized on due to high rates of IH after emergency laparotomy. All this makes the use of prophylactic mesh in the emergency setting an interesting proposition, as it may decrease the rate of IHs. However, there are concerns over potential mesh related complications including infection, chronic pain, seromas and bowel fistulas especially in emergency situations like peritonitis and intestinal obstruction. There is preliminary evidence published about the safety and efficiency of the prevention of IHs using meshes in the emergency laparotomy closure even in contaminated conditions.

In the resent systematic review and meta-analysis, only results of 2 studies and altogether 299 patients were eligible for the analysis. Swiss case-control study reported an IH rate of 3,2% (2/63) in the mesh group and 28,6% (20/70) in the control group. Spanish study group had the same kind of results in their retrospective cohort; IH rate of 5,9% (3/50) in the mesh group and 33,3% (33/100) in the control group. There was no statistically significant difference in the incidence of surgical site infection or other complications when prophylactic mesh group was compared to standard closure group. SSI rate in Swiss study was 60% and respectively only 17% in the Spanish study. This may reflect differences in the patient selection, therefore the safety profile of the prophylactic mesh in the emergency setting has not been adequately described. Neither of the studies included in meta-analysis were not randomized controlled trials. There were also many methodological differences including patient selection, used mesh, and mesh placement. Thus, the conclusion of the systematic review paper was that there are limited data to assess the effect or safety of the use of prophylactic mesh in the emergency laparotomy setting. Randomized control trials are required to address this important clinical question. EHS guideline group resulted the same conclusion in their recommendation report.

There are about 1650 patients are operated in Finland because of IH every year. According to the European study, the estimated cost for IH surgery is 6450 euros. The corresponding costs in Sweden were even higher reaching 9060 euros per treatment. Extrapolated to Finland, this means that operative treatment of IHs cause more than 10 million expenses to the Finnish health care sector in a year. Some of these costs may be avoidable by using the prophylactic mesh during the closure of midline emergency laparotomies in the patients with IH risk factors.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Incisional Hernia Emergency Laparotomy Midline Laparotomy Hernia Prevention

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention group

Prophylactic self gripping mesh (Program, Medtronic) will be placed in rectorectus space to prevent incisional hernia.

Group Type EXPERIMENTAL

Prophylactic self gripping mesh

Intervention Type DEVICE

Prophylactic self gripping mesh, Propgrip by Medtronic.

Control group

Abdomen of the patients in the control group will be closed by using small stitch closure with suture to wound length of 4:1 and slowly absorbable monofilament suture.

Group Type ACTIVE_COMPARATOR

Slowly absorbable continuous monofilament suture

Intervention Type DEVICE

Fascial closure by continuous slowly absorbable 4:1 suture

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Prophylactic self gripping mesh

Prophylactic self gripping mesh, Propgrip by Medtronic.

Intervention Type DEVICE

Slowly absorbable continuous monofilament suture

Fascial closure by continuous slowly absorbable 4:1 suture

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Midline emergency laparotomy for any gastrointestinal indication

Exclusion Criteria

* • Previous ventral hernia repair with mesh in the midline

* Previous inguinal or femoral hernia repair by any technique with mesh is accepted

* Previous WHO class of physical activity 3-4 (WHO 3 more than 50% of time at rest, WHO 4 stays at rest most of the time)
* Relaparotomy
* Indication for laparotomy is incarcerated hernia
* Pregnant or suspected pregnancy
* \<18 years
* Metastastic malignancy of any origin
* Planned osteomyelitis
* Patients living geographically distant and/or unwilling to return for follow-ups
* No informed consent
* Abdomen is left open
* Second look laparotomy planned
* Ostomy created at the operation
* Inability to keep the mesh securely out of the peritoneal cavity or close the anterior fascia
* Intra-abdominal malignancy diagnosed at the operation
* \>2 cm hernia in midline
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Helsinki University Central Hospital

OTHER

Sponsor Role collaborator

University of Oulu

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Elisa Mäkäräinen

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Elisa Mäkäräinen-Uhlbäck, M.D.

Role: PRINCIPAL_INVESTIGATOR

Oulu University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Jorvi Hospital

Espoo, , Finland

Site Status

Helsinki University Hospital

Helsinki, , Finland

Site Status

Lahti Central Hospital

Lahti, , Finland

Site Status

Oulu University Hospital

Oulu, , Finland

Site Status

Seinäjoki Central Hospital

Seinäjoki, , Finland

Site Status

Tampere University Hospital

Tampere, , Finland

Site Status

Turku University Hospital

Turku, , Finland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Finland

References

Explore related publications, articles, or registry entries linked to this study.

Makarainen E, Tolonen M, Sallinen V, Mentula P, Leppaniemi A, Ahonen-Siirtola M, Saarnio J, Ohtonen P, Muysoms F, Rautio T. Prophylactic retrorectus mesh versus no mesh in midline emergency laparotomy closure for prevention of incisional hernia (PREEMER): study protocol for a multicentre, double-blinded, randomized controlled trial. BJS Open. 2022 Jan 6;6(1):zrab142. doi: 10.1093/bjsopen/zrab142.

Reference Type DERIVED
PMID: 35143628 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

3/2020

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.